Significance of Expression of Human METCAM/MUC18 in Nasopharyngeal Carcinomas and Metastatic Lesions |
Lin, Jin-Ching
(Department of Radiation Oncology, Taichung Veterans General Hospital)
Chiang, Cheng-Feng (Department of Microbiology and Immunology, Emory University School of Medicine) Wang, Shur-Wern (Department of Microbiology and Immunology, Emory University School of Medicine) Wang, Wen-Yi (Department of Basic Medicine, Hung Kuang University) Kwan, Po-Cheung (Department of Pathology, Taichung Veterans General Hospital) Wu, Guang-Jer (Department of Microbiology and Immunology, Emory University School of Medicine) |
1 | Zeng GF, Cai SX, Wu GJ (2011). Up-regulation of METCAM/ MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells. BMC Cancer, 11, 113. DOI ScienceOn |
2 | Yoshizaki T (2002). Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol, 17, 845-50. |
3 | Yu Y, Dong W, Zhou X, et al (2004). The significance of soluble intercellular adhesion molecule 1 (ICAM-1) and transformation growth factor alpha in patients with nasopharyngeal carcinomas. Acta Otolaryngol Head Neck Surg, 130, 1205-8. DOI ScienceOn |
4 | Zeng GF, Cai SX, Liu Y, et al (2012a). METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells. Gene, 492, 229-38. DOI ScienceOn |
5 | Zeng Q, Li W, Lu D, et al (2012b). CD146, an epithelialmesenchymal transition inducer, is associated with triplenegative breast cancer. Proc Natl Acad Sci USA, 109, 1127-32. DOI |
6 | Wu GJ, Fu P, Chiang C, et al (2005). Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urology, 173, 1778-83. DOI ScienceOn |
7 | Wu GJ (2004). The role of MUC18 in prostate carcinoma. In: Hayat MA, editor. Immunohistochemistry and in situ hybridization of human carcinoma. Vol 2. Molecular pathology, lung carcinoma, breast carcinoma, and prostate carcinoma. Amsterdam: Elsevier Science/Academic Press; pp. 347-58. |
8 | Wu GJ, Peng Q, Fu P, et al (2004). Ectopic expression of human MUC18 increases metastasis of human prostate cancer cells. Gene, 327, 201-13. DOI ScienceOn |
9 | Wu GJ (2005). METCAM/MUC18 expression and cancer metastasis. Curr Genomics, 6, 333-49. DOI ScienceOn |
10 | Wu GJ, Fu P, Wang SW, et al (2008). Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res, 6, 1666-77. DOI ScienceOn |
11 | Wu GJ, Wu MWH, Liu Y (2011). Enforced expression of human METCAM/MUC18 increases the tumorigenesis of human prostate cancer cells in nude mice. J Urology, 185, 1504-12. DOI ScienceOn |
12 | Wu GJ (2012). Dual roles of METCAM in the in the progression of different cancers. J Oncol, 2012, 853797. |
13 | Schlagbauer-Wadl H, Jansen B, Muller M, et al (1999). Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int J Cancer, 81, 951-5. DOI |
14 | Xie S, Luca M, Huang S, et al (1997). Expression of MCAM/ MCU18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res, 57, 2295-303. |
15 | Yang H., Wang SW, Liu Z, et al (2011). Isolation and characterization of murine MUC18 cDNA gene, and correlation of MUC18 expression in murine melanoma cell lines with metastatic ability. Gene, 265, 133-45. |
16 | Yi ZC, Wang H, Zhang GY, et al (2006). Downregulation of connexin 43 in nasopharyngeal carcinoma cells is related to promoter methylation. Oral Oncol, 43, 898-904. |
17 | McGary EC, Heimberger A, Mills L, et al (2003). A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vitro. Clin Cancer Res, 9, 6560-6. |
18 | Raab-Traub N (1992). Epstein-Barr virus and nasopharyngeal carcinoma. Semin in Cancer Biol, 3, 297-307. |
19 |
Roberts AB, Wakefield LM (2003). The two faces of transforming growth factor beta (TGF- |
20 | Shih IM (1999). The role of CD146 (Mel-CAM) in biology and pathology. J Pathol, 189, 4-11. DOI |
21 | Tsai CN, Tsai CL, Tse KP, et al (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the down-regulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA, 99, 10084-9. DOI ScienceOn |
22 | Wei W, Sham JS (2005). Nasopharyngeal carcinoma. Lancet, 365, 2041-54. DOI ScienceOn |
23 |
Li Z, Ren Y, Lin SX, et al (2004). Association of E-cadherin and |
24 |
Wei YS, Zhu YH, Du B, et al (2007). Association of transforming growth factor |
25 | Wu GJ, Varma VA, Wu MWH, et al (2001a). Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate, 48, 305-15. DOI ScienceOn |
26 | Wu GJ, Wu MWH, Wang SW, et al (2001b). Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cells and tissues with malignant progression. Gene, 279, 17-31. DOI ScienceOn |
27 | Lee AWM, Ng WT, Chan YH, et al (2012). The battle against nasopharyngeal cancer. Radiother Oncol, 104, 272-278. DOI ScienceOn |
28 | Lehmann JM, Reithmuller G, Johnson JP (1989). MUC18, a marker of tumor progression in human melanoma. Proc Natl Acad Sci USA, 86, 9891-5. DOI |
29 | Li Q, Yu Y, Bischoff J, et al (2003). Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathology, 201, 296-302. DOI ScienceOn |
30 | Ausubel FM, Brent R, Kingston RE, et al (1987). Current Protocols in Molecular Biology. New York: Green Publishing Associates and Wiley-Interscience Press; 4.9. |
31 | Cavallaro U, Christofori G (2004). Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer, 4, 118-32. DOI ScienceOn |
32 | Lung HL, Bangarusamy DK, Xie D, et al (2005). THY1 is a candidate tumor suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene, 24, 6525-32. |
33 | Lin CT, Wong CI, Chan WY, et al (1990). Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest, 62, 713-24. |
34 | Lin CT, Chan WY, Chen W, et al (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest, 68, 716-27. |
35 | Lung HL, Cheng Y, Kumaran MK, et al (2004). Fine mapping of the 11Q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer, 112, 628-35. DOI ScienceOn |
36 | Chiang CF, Son EL, Wu GJ (2005). Oral treatment of male TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Prostate, 64, 408-18. DOI ScienceOn |
37 | Chomczyuski P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem, 162, 156-9. |
38 | Craefor NPS, Hunter KW (2006) New perspectives on hereditary influences in metastatic progression. Trends in Genetics, 22, 555-61. DOI ScienceOn |
39 | De The' G (1982). Epidemiology of Epstein-Barr virus and associated diseases. In: Roizman B, editor. The Herpesviruses. New York: Plenum Press; Vol 1, pp. 25-87. |
40 | Hassen E, Farhat K, Gabbouj S, et al (2007). TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet, 175, 41-6. DOI ScienceOn |
41 | Ho JHC (1972). Current knowledge of the epidemiology of nasopharyngeal carcinoma (NPC). In: Biggs P, de The' G, Payne L, eds. Oncogenesis and Herpesviruses. Lyon: IARC; pp. 357-66. |
42 | Krishna SM, Kattoor J, Balaram P (2005). Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomarker, 1, 271-7. |
43 | Huang GW, Mo WN, Kuang GQ, et al (2001). Expression of p16, nm-23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinomas. Laryngoscope, 111, 1465-71. DOI ScienceOn |
![]() |